BioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures
Source: SeekingAlpha
2026-03-05 15:16:32 ET
More on BioLargo
- BioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on BioLargo
- Historical earnings data for BioLargo
- Financial information for BioLargo
Read the full article on Seeking Alpha
For further details see:
BioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures
Biolargo Inc
NASDAQ: BLGO
BLGO Trading
-1.54% G/L:
$0.166 Last:
20,271 Volume:
$0.1629 Open:
BLGO Latest News
March 04, 2026 10:30:00 am
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
